New Developments at Olympus Diagnostica
|
By Labmedica staff writers Posted on 20 Apr 2005 |
|
Olympus Diagnostica GmbH (Hamburg, Germany) has announced that the company has changed its name to Olympus Life & Material Science Europa GmbH, amalgamating the fields of diagnostics and microscopy.
In another new development, Olympus Life and Material Science Europa GmbH has acquired the privately held microfluidics company Advalytix AG (Brunnthal, Germany). Olympus states that the extremely broad application spectrum and innovative technologies of Advalytix will provide it with additional potential to nurture expansion and maximize business growth.
Microfluidics is a key technology for diagnostics and molecular biology research used to manipulate liquids in submicroliter range. The miniaturization of liquid volumes meets an ever-growing demand to conserve both scarce samples and expensive reagents. Advalytix, which developed the SlideBooster hybridization and AdvaWash washing stations, is also developing products and protocols for the genetic analysis of single cells.
"The acquisition of Advalytix represents great short-, mid-, and long-term opportunities for Olympus Life and Material Science,” noted Dr. Helmut Koehler, executive managing director of Olympus Life and Material Science. "It positions Olympus at the very forefront of the latest technological developments in life science and allows us to sustain our above-average growth as well as profiting from the future developments in this rapidly expanding specialist area.”
In another move, to increase floor space and handle future expansion, the research and development center of Olympus for immunoassays has been moved to Rungis, a technology area south of Paris (France). The center will be housed in the same building as the head office of the diagnostics division of Olympus France. Work in the laboratory will focus on the development of heterogeneous immunoassays for the new Olympus AU3000i immuno-analyzer to be released in November 2006.
Related Links:
Olympus Life & Material Science
In another new development, Olympus Life and Material Science Europa GmbH has acquired the privately held microfluidics company Advalytix AG (Brunnthal, Germany). Olympus states that the extremely broad application spectrum and innovative technologies of Advalytix will provide it with additional potential to nurture expansion and maximize business growth.
Microfluidics is a key technology for diagnostics and molecular biology research used to manipulate liquids in submicroliter range. The miniaturization of liquid volumes meets an ever-growing demand to conserve both scarce samples and expensive reagents. Advalytix, which developed the SlideBooster hybridization and AdvaWash washing stations, is also developing products and protocols for the genetic analysis of single cells.
"The acquisition of Advalytix represents great short-, mid-, and long-term opportunities for Olympus Life and Material Science,” noted Dr. Helmut Koehler, executive managing director of Olympus Life and Material Science. "It positions Olympus at the very forefront of the latest technological developments in life science and allows us to sustain our above-average growth as well as profiting from the future developments in this rapidly expanding specialist area.”
In another move, to increase floor space and handle future expansion, the research and development center of Olympus for immunoassays has been moved to Rungis, a technology area south of Paris (France). The center will be housed in the same building as the head office of the diagnostics division of Olympus France. Work in the laboratory will focus on the development of heterogeneous immunoassays for the new Olympus AU3000i immuno-analyzer to be released in November 2006.
Related Links:
Olympus Life & Material Science
Gold Member
Veterinary Hematology Analyzer
Exigo H400
New
PSA Test
Humasis PSA Card
New
Pipet Controller
Stripettor Pro
Latest Industry News
- Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
- Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
- New Collaboration to Advance Microbial Identification for Infectious Disease Diagnostics
- Tecan Acquires ELISA Immunoassay Assets from Revvity's Cisbio Bioassays
- Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration
- Philips and Ibex Expand Partnership to Enhance AI-Enabled Pathology Workflows
- Grifols and Inpeco Partner to Deliver Transfusion Medicine ‘Lab of The Future’
- Research Collaboration to Advance AI-Enhanced, Real-Time Optical Imaging in Lung Cancer Biopsy
- CACLP 2025 Unites Global Innovators in IVD Industry
- Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
- ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
- New Partnership Revolutionizes Analyses of Biological Samples
- Medlab Middle East Looks to The Future of Laboratories
- Medix Biochemica Acquires German Immunoassay Solutions Developer Candor Bioscience
- bioMérieux Acquires Norwegian Immunoassay Start-Up SpinChip Diagnostics
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
New Genetic Tool Analyzes Umbilical Cord Blood to Predict Future Disease
Children are experiencing metabolic problems at increasingly younger ages, placing them at higher risk for serious health issues later in life. There is a growing need to identify this risk from birth... Read more
Spinal Fluid Biomarker for Parkinson’s Disease Offers Early and Accurate Diagnosis
Parkinson’s disease is a neurodegenerative condition typically diagnosed at an advanced stage based on clinical symptoms, primarily motor disorders. However, by this time, the brain has already undergone... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
